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Protein phosphorylation plays an essential role in the generation of circadian rhythms, regulating the stability, activity,
and subcellular localization of certain proteins that constitute the biological clock. This study examines the role of the
protein kinase Doubletime (DBT), a Drosophila ortholog of human casein kinase I (CKI)e/d. An enzymatically active DBT
protein is shown to directly phosphorylate the Drosophila clock protein Period (PER). DBT-dependent phosphorylation
sites are identified within PER, and their functional significance is assessed in a cultured cell system and in vivo. The
per
S mutation, which is associated with short-period (19-h) circadian rhythms, alters a key phosphorylation target
within PER. Inspection of this and neighboring sequence variants indicates that several DBT-directed phosphorylations
regulate PER activity in an integrated fashion: Alternative phosphorylations of two adjoining sequence motifs appear
to be associated with switch-like changes in PER stability and repressor function.
Citation: Kivima ¨e S, Saez L, Young MW (2008) Activating PER repressor through a DBT-directed phosphorylation switch. PLoS Biol 6(7): e183. doi:10.1371/journal.pbio.
0060183
Introduction
Circadian rhythms (;24-h rhythms) in physiology and
behavior are observed in almost all phyla. In fungi, plants,
and animals, cell autonomous, autoregulatory gene and
protein interactions promote circadian molecular oscilla-
tions. Most of the genes and proteins that make up such
clocks are not conserved between phyla, suggesting that
circadian clocks may have evolved independently in bacteria,
fungi, plants. and animals. Notable exceptions are the protein
kinases CK1 and CK2. The former is known to play a central
role in both animal and fungal clocks, while CK2 has been
shown to be essential for animal and plant circadian
rhythmicity [1]. Although in certain cases cycling clock gene
transcription can be eliminated without suppressing circa-
dian rhythmicity, protein phosphorylation appears to be
essential for persistent clock function [2].
The circadian clock of Drosophila melanogaster is composed
in part of two interconnected feedback loops [3]. In the period/
timeless (per/tim) loop, CLOCK (CLK) and CYCLE (CYC), two
transcription factors of the bHLH/PAS superfamily, hetero-
dimerize and activate per and tim transcription during the
afternoon and early evening. In turn, after nuclear trans-
location and binding to CLK/CYC heterodimers, PER, and
possibly TIM, repress their own transcription during late
night and early morning [4]. In the Clock (Clk) loop, circadian
transcription of vrille (vri) and of Par domain protein 1e (Pdp1e)
is driven by CLK/CYC heterodimers, and subsequently, VRI
negatively regulates the transcription of Clk. Still later, Pdp1
renews expression of Clk [5]. Pdp1 may also have a role in
mediating circadian clock output [6].
Most proteins involved in these transcriptional feedback
loops are phosphorylated in a time-of-day–dependent man-
ner, and three kinases, casein kinase I (CKI)e/d/Doubletime
(DBT), CK2, and GSK-3/Shaggy (SGG), have been identiﬁed as
essential clock components in Drosophila. Importantly, a
mutation of the human ortholog of DBT, CKId, has been
associated with certain forms of a heritable disorder of sleep,
familial advanced sleep phase syndrome (FASPS; [7]). The
disorder may reﬂect altered phosphorylation of PER2, as
FASPS has also been associated with mutation of a putative
CKIe/d phosphorylation site within PER2 [8]. Preliminary
studies of the prevalence of FASPS indicate that the disorder
may affect as much as 0.3% of the United States population
(C. R. Jones and L. J. Ptacek, unpublished data).
DBT is constitutively expressed at the mRNA and protein
level, and is an essential gene for ﬂy development, regulating
cell survival and proliferation [9–11]. Loss of DBT activity is
associated with hypophosphorylation and stabilization of
PER, indicating its role in determining the rate of PER
degradation [12]. DBT has been shown to physically interact
with PER in vitro and in vivo, and to create a stable complex
with PER throughout the circadian cycle [9,10]. PER that has
been phosphorylated by DBT is recognized by the Slimb
protein [13]. Slimb is a component of the Skp1/Cullin/F-box
protein (SCF) ubiquitin ligase complex, which marks proteins
for proteosomal degradation in a phosphorylation-depend-
ent manner [14]. Enhanced PER degradation in the cytoplasm
is predicted to delay nuclear translocation of both PER and
TIM, and to thus affect the period of circadian rhythms [12].
The mutation dbt
S, associated with an amino acid sub-
stitution (proline to serine at residue 47 [P47S]), shortens
period length by about 6 h. dbt
L, with an amino acid
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PLoS BIOLOGYsubstitution of isoleucine for methionine at residue 80
(M80I), lengthens period to 29 h. A third mutation, dbt
AR,i s
associated with a change from histidine 126 to tyrosine
(H126Y) and causes arrhythmia. PER protein in this mutant is
hypophosphorylated [15]. Each of these mutations maps to
the kinase domain of DBT [16]. The short- and long-period
alleles of DBT enhance or attenuate, respectively, PER
degradation in the nucleus, further demonstrating the
importance of timely PER degradation as a critical determi-
nant in establishing 24-h rhythmicity. In addition to
inﬂuencing protein degradation, DBT appears to affect the
timing of nuclear accumulation of PER: The short-period
mutant dbt
S shows delayed PER nuclear accumulation that is
apparently independent of PER protein stability [17], and
arrhythmic alleles of dbt cause constitutive nuclear accumu-
lation of PER in clock-containing cells of larval and adult
Drosophila [18,19]. Lastly, in cultured cells reduction of DBT
activity by RNA interference (RNAi) has been reported to
reduce the potency of PER as a transcriptional repressor [20].
Thus, DBT appears to regulate different aspects of PER
function in multiple steps throughout the circadian cycle.
The mutation per
S, which shortens period length to 19 h,
was among the ﬁrst circadian rhythm mutations isolated in
Drosophila [21]. The mutation replaces serine with asparagine
at amino acid (aa) position 589 (S589N) [22,23]. Similar, short-
period behavioral phenotypes are produced by a wide variety
of missense mutations affecting a region of approximately 20
aa encompassing the site of the per
S mutation. The prevalence
of such mutations suggests that short-period phenotypes may
result from loss or depression of function in this region of the
PER protein, which we will refer to as the ‘‘per-short domain’’
[24,25]. Importantly, the per-short domain has been impli-
cated in the trans-regulation of DBT: mutations of this PER
domain restore function to a kinase-deﬁcient mutant, dbt
AR,
suggesting that the wild-type form of the per-short domain
may inﬂuence a temporal sequence of DBT-dependent
phosphorylation(s) of PER [15].
In this paper, we describe genetic and biochemical
approaches that have allowed the mapping of DBT-directed
PER phosphorylation sites. These maps derive from inter-
actions of Drosophila DBT and PER in vitro, and their
functional signiﬁcance has been explored in a cultured cell
model and in living ﬂies. Our studies have shown that the per-
short domain and a neighboring segment of PER are
preferentially phosphorylated by DBT. These adjoining
domains appear to serve as alternative targets for DBT-
directed phosphorylation. Interactions between these PER
domains and DBT appear to provide a switch, giving either an
unstable, highly active PER repressor, or a stable PER protein
with little activity.
Results
Generation of Enzymatically Active DBT
Baculoviral expression in Sf9 cells was chosen for DBT
production in an effort to recover kinase activity. Initially,
efforts made to synthesize this Drosophila protein in bacterial
cells (Escherichia coli) failed to produce enzymatically active
DBT protein. Importantly, production of active mammalian
CKIe using the same conditions in bacterial cells was
successful, suggesting a speciﬁc problem emanating from
the expressed DBT protein. Two baculoviruses were con-
structed. One expressed wild-type DBT, whereas a second
generated a mutant form of DBT in which the putative ATP
binding lysine (aa 38) was mutated to alanine (K38A). Several
amino acid changes at this site have been previously shown to
produce inactive CKI kinases [26]. Recombinant proteins
were expressed as N-terminal glutathione S-transferase
(GST)-fusion proteins to facilitate their puriﬁcation. GST-
DBT proteins were isolated 48 h after infection and initially
tested for kinase activity using casein as an in vitro substrate.
Whereas the fusion protein containing the wild-type DBT
sequence produced strong phosphorylation of casein, the
K38A mutant showed little or no activity (Figure 1A). This
result demonstrates that DBT expression in Sf9 cells
produces enzymatically active kinase and that the puriﬁed
kinase activity is dependent on the DBT primary sequence.
Recently, Muskus et al. [19] showed that a related (K38R) DBT
mutant inhibits wild-type DBT function in a cultured cell
phosphorylation assay and in behavioral tests of transgenic
Drosophila.
Enzymatic Activities of DBT Mutants Affecting Circadian
Clock Function
Since DBT functions as a protein kinase, it is important to
determine whether period-altering mutations that affect its
structure also modify its biochemical activity. Single amino
acid changes were introduced into the baculovirus construct,
and mutant and wild-type kinases were puriﬁed in parallel.
Thereafter, brief, timed kinase assays were performed using
casein as a substrate (Materials and Methods). Each of the
mutations decreased the kinase activity of DBT, but to
varying degrees (Figure 1B). The most dramatic reduction was
observed in the presence of the dbt
AR mutation (Figure 1B,
lane 1). When normalized to the kinase protein levels (Figure
1C), approximately 10% of the wild-type level of activity is
preserved in DBT
AR. The dbt
L mutation reduced kinase
activity to approximately 30% that of wild type. The dbt
S
mutation, which speeds up the clock in vivo, also reduced
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Author Summary
Most proteins involved in circadian transcriptional feedback loops
undergo reversible chemical modifications (called phosphorylation)
that regulate their activity in a time-of-day–dependent manner.
Doubletime (DBT), a Drosophila kinase, phosphorylates the circadian
transcriptional repressor PERIOD (PER). Mutations of dbt shorten or
lengthen the period of circadian behavioral rhythms, or abolish the
rhythms altogether in flies. A mutation of the human ortholog of
dbt, casein kinase I (CKI)d, has been associated with certain forms of a
heritable sleep disorder. The disorder may reflect altered activity of a
human PER protein, as the syndrome can also be caused by
mutation of a CKIe/d phosphorylation site within PER2. In this study,
we locate DBT-directed phosphorylation sites in the Drosophila PER
protein, including a DBT target region of PER that was previously
shown to regulate DBT activity. Two PER domains within this region
appear to serve as alternative targets for DBT. Phosphorylation of
the upstream domain seems to suppress phosphorylation elsewhere
in the region, producing a stable PER protein with little activity as a
transcriptional repressor. However, when phosphorylation of the
upstream domain is blocked, downstream DBT targets appear to be
phosphorylated, producing a highly active, but short-lived repressor.
Our results suggest that ordered patterns of DBT-directed phos-
phorylation contribute to the timing of PER’s function and
disappearance, and thus influence the pace of the circadian clock.DBT activity by approximately 15% compared to wild type.
The reduction of kinase activity by both period-shortening
and lengthening mutations of dbt suggests complex regulation
of the clock by DBT. Indeed, there is a precedent for such
regulation in the case of a mammalian ortholog of DBT; the
hamster CKI mutant tau speeds up the clock by promoting
PER phosphorylations only at speciﬁc target sites and
decreasing PER stability [27].
DBT Phosphorylation of Clock Proteins
Availability of enzymatically active DBT allowed us to
evaluate its action on clock-related substrates directly.
Several clock proteins were expressed as GST fusions, and
each was puriﬁed from E. coli and characterized with respect
to its potential as a DBT substrate in vitro. Figure 2 shows
that DBT speciﬁcally phosphorylated a GST-PER fusion
protein encompassing the ﬁrst 640 amino acids of Drosophila
PER (Figure 2, lane 11). In contrast, no signiﬁcant phosphor-
ylation was observed for fusion proteins composing most of
TIM, the N-terminal half of CLK, or full-length CYC and SGG
(Figure 2). This experiment established that PER from
Drosophila can be directly phosphorylated by the enzyme
encoded by Drosophila dbt.
Next, a more comprehensive mapping of the DBT-directed
phosphorylation sites of PER was undertaken. A panel of
overlapping GST fusion proteins was generated that together
encompassed the full 1,224–amino acid sequence of Drosophila
PER. Each fusion protein was allowed to react brieﬂy with
recombinant DBT in an effort to identify preferred DBT
targets (Materials and Methods). Figure 3 shows patterns of
phosphorylation for 17 PER fragments that deﬁne three
regions of the protein that can serve as high-afﬁnity in vitro
targets for DBT.
PER 1–640, whose phosphorylation was initially observed in
this way, was further subdivided to resolve two DBT target
regions. A fusion protein containing the N-terminal 365
amino acids of PER was phosphorylated by DBT (Figure 3,
lane 7), whereas a subfragment of this region, containing aa
170–365, was not (Figure 3, lane 9). In addition, PER 149–365
GST fusion protein showed a high level of phosphorylation
(Figure 3, lane 8), indicating that the phosphorylated region
closest to the N-terminus of PER is located between residues
149 and 170.
Sequences between aa 170 and 580 were not signiﬁcantly
phosphorylated by DBT (Figure 3, lanes 4, 6, and 9). Also, PER
650–700 was not phosphorylated by DBT (Figure 3, lane 2);
however, strong phosphorylation of PER 570–645 was
observed. Thus, a second phosphorylation region should
reside between aa 580–645.
DBT also phosphorylated a fusion protein corresponding
to the C-terminal half of PER (encoding residues 650–1,224)
(Figure3, lane 17). Despite the presence of a multitude of C-
terminal degradation products of this protein, only the
highest mobility forms were signiﬁcantly phosphorylated,
suggesting that this DBT target occurs close to the C-terminus
of PER. Shorter PER fragments collectively encoding residues
947–1,136 were not phosphorylated by DBT (Figure 3, lanes
12, 13, and 14). The strong phosphorylation of GST-PER
1,101–1,224 places the C-terminal DBT target within PER
1,136–1,224.
To summarize, in vitro DBT appears to preferentially
phosphorylate sequences in three discrete regions of PER: aa
Figure 1. Activity of Recombinant DBT Purified from Sf9 Cells
(A) Recombinant DBT purified from Sf9 cells has protein kinase activity. GST-DBT and GST-DBT (K38A) proteins purified from Sf9 cells were incubated
with casein and radioactive P-32 labeled c-ATP in kinase buffer. Casein is strongly phosphorylated by GST-DBT. Mutant GST-DBT (K38A) substantially
reduces casein phosphorylation. The lower panel indicates the amount of GST-DBT and GST-DBT (K38A) used in the kinase assay as detected by western
blot with anti-DBT antibody. Molecular weight markers are shown on the left.
(B) DBT mutations affecting behavioral rhythms also affect kinase activity. Either wild-type DBT (DBT), DBT arrhythmic (DBT
AR), long- (DBT
L) or short-
(DBT
S) period rhythm mutants were expressed and purified as GST fusion proteins from Sf9 cells, and used to phosphorylate casein. Top: GST-DBT levels
measured by anti-GST western blot. Bottom: equal amounts of casein were phosphorylated with wild-type GST-DBT (lane 4) or with mutant GST-DBT
proteins: GST-DBT
AR (lane 1), GST-DBT
L (lane 2), and GST-DBT
S (lane 3).
(C) Kinase activity of GST-DBT fusion proteins. Relative kinase activity is shown as a ratio of the casein phosphorylation signal to total GST-DBT level.
Relative kinase activity of wild-type GST-DBT was set as 1.
doi:10.1371/journal.pbio.0060183.g001
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DBT-Directed Phosphorylation of PER149–170, aa 580–645, and aa 1,136–1,224. All of these regions
are serine- and threonine-rich (17%–26%). However, as
further discussed below, a sequence motif previously impli-
cated as a preferential target for phosphorylation in
mammalian studies of CKI (S/TXXS/T) is encountered in only
one of the target regions of PER. Although we have not
determined whether the PER phosphorylation sites detected
in vitro correspond to sites phosphorylated in vivo, the
limited duration of the in vitro kinase assay is likely to favor
phosphorylation of higher afﬁnity sites, rather than secon-
dary, nonspeciﬁc sites. Our analysis does not exclude the
possibility that DBT phosphorylates PER at other sites in vivo.
Identification of Individual DBT Phosphorylation Sites in
PER
In order to deﬁne individual phosphorylation sites, three
fusion proteins were chosen for phosphopeptide analyses.
Fusion proteins (GST-PER149–365, GST-PER580–645, and
GST-PER1101–1224) from each DBT target region were
phosphorylated by recombinant DBT in the presence of
radiolabeled ATP, and the resulting phosphorylated PER
proteins isolated and subsequently digested with trypsin for
further analysis (Materials and Methods). Table 1 shows the
identiﬁed phosphopeptide sequences with phosphorylated
residues indicated. The bulk of the radioactivity in the N-
terminal PER target was located in one long peptide that
contained the last 16 amino acids of GST followed by the ﬁrst
27 amino acids of the fused PER sequence. The long N-
terminal sequence composing the GST portion of the fusion
protein precluded a further analysis by Edman sequencing.
The recovery of this tryptic phosphopeptide (PER aa 149–
176) was consistent with our earlier mapping of a preferential
phosphorylation site(s) between aa 149 and aa 170. The amino
acid sequence of the latter PER interval contains ﬁve serine
residues at positions 149, 151, 153, 164, and 169. These
residues are therefore potential substrates for DBT in the N-
terminus of PER.
Phosphorylation of GST-PER580–645 was predominantly
associated with the three tryptic peptides shown in Table 1.
The masses of each of these declined in response to alkaline
phosphatase and propanethiol treatment (Materials and
Methods). Amino terminal sequencing of these peptides,
coupled with mass spectrometry, showed that the modiﬁed
residues correspond to serines 589, 607, 613, and 629, and
threonine 610. However, mass spectroscopy also indicated
that none of the three peptides was detectably phosphory-
lated at multiple sites. Thus, each tryptic fraction proved to
be a mixture of alternatively phosphorylated versions of the
same peptide. Serine 604 was not amenable to Edman
sequencing due to its position at the end of a longer tryptic
peptide. This residue is part of a CKI consensus sequence
(SKSS) that also includes serine 607, which was shown to be
phosphorylated as indicated above.
Two phosphopeptides were derived from the C-terminal
fusion protein GST-PER1101–1224. Sequencing and mass
spectrometry of these revealed one phosphorylated residue in
each peptide, corresponding to serine 1,134 and threonine
1,219. Figure 4 shows a schematic representation of the
identiﬁed DBT phosphorylation sites in PER in relation to
previously recognized functional domains.
Analysis of PERIOD Phosphorylation Site Mutants in
Cultured S2 Cells
To examine the relevance of each DBT-derived phosphor-
ylation of PER, site-directed mutagenesis of a per cDNA was
performed. Full-length mutant proteins were subsequently
expressed under control of an actin promoter and tested for
their relative activity as transcriptional repressors in
Schneider line 2 (S2) cultured Drosophila cells. This cultured
cell assay measures CLK-dependent activation of the per
promoter, comparatively, in the absence and presence of
PER. A standard luciferase assay is employed to measure the
effect of PER on CLK activity, so that relative luciferase levels
that are expressed under the control of the per promoter
report the CLK-dependent activation of transcription (cf.
[20,28]). Selected sites were mutated individually, and some
sites were also mutated combinatorially to investigate
possible interactions between different phosphorylation
targets. In all cases, each substitution was to alanine. Thirteen
PER mutants were tested in this fashion, with the results
shown in Figure 5A.
Mutations of the N-terminal and C-terminal PER phos-
phorylation sites had no detectable effect on PER’s activity as
a repressor of CLK (compare mutants N5A and 1,134/1,219 to
wild-type PER in Figure 5A). In contrast, all mutations in the
per-short downstream (perSD, Figure4) domain reduced PER
function in this assay, and a mutation of serine 589, in the
per-short domain, enhanced PER’s activity as a CLK repressor
(Figure5A). With respect to mutations of the perSD domain,
Figure 2. DBT Preferentially Phosphorylates PER
Fragments or full-length sequences of proteins required for circadian
clock function in Drosophila were fused to GST and expressed and
purified from E. coli. Purified fusion proteins were treated with either
wild-type DBT (odd-numbered lanes) or an inactive DBT mutant (K38A)
as a negative control (even-numbered lanes). The top panel shows
autoradiograph of incorporated phosphate; the lower panel shows total
protein stained with Amido black. Molecular weight markers are
indicated to the right of each panel. Sequences fused to GST as
substrates for phosphorylation: lanes 1–2, TIM aa 507–1,150; lanes 3–4,
TIM aa 222–577; lanes 5–6, CLK (-N terminus) aa 1–600; lanes 7–8, full-
length CYC; lanes 9–10, full-length SGG; and lanes 11–12, PER amino
acids 1–640. Molecular weight markers are shown on the right.
doi:10.1371/journal.pbio.0060183.g002
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DBT-Directed Phosphorylation of PERthe inhibitory effect varied depending on the residue(s)
mutated: Strongest effects were seen in combinatorial
mutations. For example, when residues 604 and 629 were
both mutated to alanine, PER function was disabled to a
greater extent than that of either single mutant (compare
mutant 604/629 with 604 and 629 in Figure 5A). Little or no
repressor activity was observed for a combinatorial PER
mutant containing alanine substitutions at all per-short and
perSD phosphorylation sites (mutant 6A in Figure 5A).
An inverse relationship was observed between S589A and
mutations of the perSD domain. These combinations always
showed intermediate levels of PER activity that suggested a
partial restoration of function by S589A (compare mutant
589/604/629 to 604/629 and 589; 589/629 to 629 and 589; 589/
604 to 604 and 589; and 589/607/610 to 607/610 and 589 in
Figure 5A).
We further tested in the repression assay, a deletion of per
that removes the complete per-short domain ([24], see also
‘‘perDS transgenes’’ below). Following transfection of S2 cells
with equal amounts of DNA, both PER 589 and PER DS
appeared to produce greater transcriptional repression than
wild-type PER, despite the low levels of PER 589 and PER DS
protein detected in these assays (see Figure 5B). In contrast,
high levels of the PER 6A and PER 604/629 proteins produced
only weak repression, suggesting that increased or decreased
Figure 3. DBT Phosphorylates Three Regions in PER
Different fragments of PER were fused to GST and expressed and purified from E. coli. Each fusion protein was phosphorylated with recombinant DBT,
resolved in 10% SDS-PAGE, and transferred to nitrocellulose. Top panels in (A, (B), and (C) show signals from incorporated radioactive phosphate. Lower
panels in (A), (B), and (C) show total proteins stained with Ponceau S. Numbers on top of each lane indicate the amino acids in PER included in each
fusion protein. Molecular weight markers are shown on the right of each panel.
(A) shows mapping of phosphorylation in the middle of PER (between residues 570–645).
(B) shows mapping of phosphorylation near the N-terminus (between residues 149–170).
(C) shows mapping of phosphorylation near the C-terminus (between residues 1,101–1,224).
doi:10.1371/journal.pbio.0060183.g003
Table 1. Phosphopeptides Generated from
GST-PER Fusion Proteins by Reaction with DBT
DBT Substrate Identified Phosphopeptides
GST-PER143–365 -(149)- (S)G(S)E(S)EADRVEGVAK(S)EAAQ(S)-169
SDLEVLFQGPLGSPEF-
GST-PER571–645 588-DSVMLGEISPHHDYYD(S)-604
606-SSTETPPSYNQLNYNENLLR-625
626-FFNSKPVTAPAELDPPKTEPP-647
GST-PER1101–1224 1128-SSPIPSVMGDYNSDPPCS-1146
1210-IMEHPEEDQTQHGDG-1224
The first column indicates GST-PER proteins phosphorylated with DBT, numbers show the
PER amino acid sequence fused to GST. The second column indicates phosphopeptides
recovered from each phosphorylated GST-PER fusion protein. In respective rows, first and
last amino acids in each peptide are shown (numbers indicate the position of each
peptide relative to full-length PER protein sequence). Phosphorylation sites identified in
this study are underlined. In those cases in which Edman sequencing of the
phosphopeptides was not possible, potential phosphorylation sites are indicated by
parentheses. The GST-derived sequence composing the N-terminus of the GST-PER143–
365 tryptic fragment is shown in italics. Each peptide was phosphorylated only once
according to mass spectrometry. Thus, the sequencing results shown here likely represent
phosphorylation in a heterogeneous pool of phosphopeptides.
doi:10.1371/journal.pbio.0060183.t001
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DBT-Directed Phosphorylation of PERprotein levels are not responsible for the apparent changes in
activity levels. To further address this issue, we determined
the level of repression associated with wild-type and mutant
forms of PER as a function of the amount of protein present
in the assay (see Figure 5C). When normalized to the wild-type
PER protein levels, measured activities of the PER S589A and
PERDS repressors were higher than that of wild-type PER,
indicating approximately twice the activity per unit protein.
Together these S2 cell ﬁndings suggest that the PER-short
domain regulates PER stability and PER’s activity as a CLK
repressor.
The functional analysis of phosphorylation sites presented
here indicates that DBT-target residues in the per-short and
perSD domains are relevant for PER-dependent repression of
CLK. The amino acids phosphorylated by DBT in the N- and
C-terminus did not have an effect in this assay when mutated,
but may be relevant for aspect(s) of PER regulation that are
not revealed in the S2 transcription assay.
perDS Transgenes Dominantly Shorten the Period of
Locomotor Rhythms
Serine 589 is mutated in the short-period (19-h) mutant
per
S [22,23], indicating its relevance to the regulation of
Drosophila’s circadian rhythms [21]. Serine 589 is included in
the per-short domain (Figure 4), a 17–amino acid interval, aa
585–601, throughout which single amino acid substitutions
predominantly generate short-period phenotypes [24,25,29].
The latter ﬁnding suggests that short-period mutations cause
a domain-speciﬁc loss of PER function [24]. To further test
this hypothesis, a transgenic Drosophila strain was constructed
with an intragenic PER deletion, termed perDS, affecting the
entire per-short domain. The perDS transgene contained the
complete sequence encoding PER with a 51-nucleotide (nt)
in-frame deletion removing the DNA sequence encoding aa
585–601, thus also lacking serine 589, one of the identiﬁed
DBT target sites. Further transgenic lines were created by
genetic recombination. These carried one or two perDS
transgenes in homozygotes (giving two and four copies of
the transgene, respectively), or were heterozygous for one
transgene. The recombinant ﬂies were alternatively gener-
ated in wild-type or per null mutant backgrounds, and tested
for locomotor activity in constant darkness. Table 2 shows the
results of these behavioral assays (examples of individual
locomotor activity records are presented in Figure S1). A
progressive shortening of period length, and eventually
arrhythmia, was observed as the number of perDS transgenes
was increased. It has been suggested that mutations in the
per-short domain generate short-period phenotypes through
a mechanism that involves premature degradation of nuclear
PER proteins [30]. However, if this were the only mechanism
responsible for decreased period length in such mutants, it
might be expected that progressively longer periods would
result from increasing perDS copy number, in contrast to our
observations. Our results suggest that a qualitative change in
PER function contributes to these short period phenotypes.
Clock Gene Expression in perDS Drosophila
To better understand the basis of the short period behavior
of perDS ﬂies, we examined the expression patterns of Clk, tim,
vri, and pdp1. In each of these studies, per expression was
monitored by RNase protection with a probe spanning the
per-short domain allowing independent measurement of
mRNA expression from the endogenous per gene and the
perDS transgene(s).
The combined results of two independent time-course
studies are shown in each of the panels composing Figure 6. A
representative mRNA expression proﬁle from one of these
time courses is shown in Figure S2. Lower levels of expression
were observed in the transgenic animals for all genes
Figure 4. Distribution of Phosphorylated Regions in PER Relative to Functional Domains or Motifs
Colored blocks show functional domains found in PER. Three regions phosphorylated by DBT are shown as segments of PER protein sequence, with
phosphorylated residues established in this study indicated in red. Four serines between aa 143–169, as well as serine 604, are shown in blue, as they
are potential targets within DBT-derived phosphopeptides, but could not be directly assessed for phosphorylation in this study; see also the text). PAS
indicates position of PAS domain (contains aa ;220–450) [51]; CLD, cytoplasmic localization domain that promotes PER cytoplasmic localization in the
absence of TIM (aa 452–512) [52]; S, per-short domain, causes short-period behavioral rhythms when variably mutated (indicated as a green bar; 585
and 601 indicate the first and last amino acid of the motif, respectively) [24]; SD, per-short downstream domain, contains many DBT phosphorylation
sites (indicated by the red bar above the protein sequence; 604 and 629 indicate the first and last amino acids, respectively, of the region examined in
this study); CCID, CLK-CYC inhibitory domain, represses CLK-dependent transactivation when overexpressed in cultured cells [39]. (N and C indicate the
amino- and carboxy-terminal ends of the schematic PER).
doi:10.1371/journal.pbio.0060183.g004
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DBT-Directed Phosphorylation of PERmonitored, and the amplitude of residual RNA rhythmicity
was reduced. Moreover, stronger effects were observed as the
number of transgenes increased, consistent with increased
frequency of behavioral arrhythmia in these animals (Table
2).
In wild-type ﬂies, the expression of per, tim, vri, and pdp1e
peaks during the early evening (approximately Zeitgeber time
[ZT] 14; see wild type in Figure 6I, 6E, 6G, and 6A,
respectively). In contrast, expression of these genes in ﬂies
with one homozygous perDS transgene showed an advanced
phase, with peak expression time occurring in the afternoon
(;ZT 10; Figure 6I, 6E, 6G, and 6A). In each case, a lower
amplitude RNA rhythm accompanied the advance phase of
RNA expression. Corresponding alterations were observed in
the Clk mRNA accumulation proﬁle. In wild-type ﬂies, Clk
expression oscillates with a phase opposite to that of per, tim,
vri, and pdp1e. The phase of Clk RNA cycling is also advanced
in ﬂies carrying one homozygous perDS transgene (Figure 6C).
Expression levels of the perDS transcript were also
measured. perDS mRNA showed oscillatory expression in
animals with one and two homozygous perDS transgenes, with
overall high levels of expression (Figure 6K and 6L). The
observed increase in mRNA expression from perDS may be
caused by an absence of dosage compensation that would
regulate the endogenous per locus on chromosome X (both
transgenes are in Chromosome 3). In fact, trough levels of
perDS expression were comparable to peak expression levels
of endogenous per mRNA in wild-type ﬂies (Figure 6K and
6L).
PER Protein Expression in perDS Flies
The reduced expression of per, tim, vri, and pdp1e observed
in all perDS ﬂies indicated that PER proteins missing the per-
short domain are enhanced repressors of CLK, a result
consistent with the behavior of per-short domain mutations
in our cell culture assays of repressor activity (Figure 5). To
determine whether elevated PERDS protein accumulation is
associated with the heightened suppression of CLK, anti-PER
western blots were performed using ﬂies with perDS trans-
genes in a per null background. In ﬂies with one homozygous
perDS transgene, PERDS proteins were expressed rhythmically
Figure 5. Repression of CLK-Dependent Activation of per-luciferase Reporter by PER Phosphorylation Site Mutants
Bar graphs indicate relative luciferase activity levels from S2 cells cotransfected with Clk and 50 ng of either wild-type (þ) or mutant per expression
plasmids along with the per-luc reporter. Normalized luciferase activities were plotted as relative activation compared to expression in the absence of
per (–). Numbers below the graph indicate positions of serine or threonine residues in PER that were mutated to alanine (PER mutant N5A has amino
acids 149, 151, 153, 164, and 169 mutated to alanine, and PERDS has a 51-nt deletion in the per-short region as described in Materials and Methods).
(A) Repression activity of PER mutants. Sequence on top shows the DBT-mediated phosphorylation sites in the per-short and perSD domains (in red),
and the multiple residues mutated to alanine (in blue) for mutants 4A and 6A. Values are averaged over three experiments; error bars indicate standard
error of the mean. Lane 1, no added CLK. Remaining lanes, CLK plus indicated per PER repressor.
(B) Stability of the PER mutants. The assay was performed as described above with S2 cells transfected with equal amounts (50 ng) of mutant or wild-
type per DNA. The panel at the top shows the amount of PER protein detected by western blot analysis at the time the luciferase assay was conducted.
In this case, equivalent, small samples of the luciferase assays were subjected to SDS-PAGE, and the presence of PER protein was detected using anti-
PER antibodies.
(C) Quantification of per-luc repression by PER mutants as a function of the amount of PER protein. Increasing amounts of per
þ and per mutant DNA
were used to transfect S2 cells. In three independent experiments, the level of repression was determined as described above, and the amount of PER
present in each assay quantified by western blot. The levels of repression shown represent activity per unit protein as assessed by the comparison of
the quantified western blots. This comparison indicates that PER S589A and PERDS are both more active repressors than the wild-type PER protein.
doi:10.1371/journal.pbio.0060183.g005
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DBT-Directed Phosphorylation of PERin light/dark (LD) cycles (Figure 7) and also in dark/dark (DD;
unpublished data). PERDS peak levels were advanced in these
ﬂies by 4 h when compared to PER accumulation proﬁles in
wild-type ﬂies (Figure 7). However, the abundance of PERDS
did not signiﬁcantly differ from that seen for PER in wild-
type ﬂies. This was unexpected since a high level of perDS
mRNA expression was found in these ﬂies. The lack of
protein overexpression in the presence of elevated mRNA
levels is likely to indicate that PERDS proteins are not as
stable as wild-type PER proteins.
In the lines carrying two homozygous perDS transgenes,
PERDS protein levels were further reduced (Figure 7).
Remarkably, PERDS proteins accumulated with a modest
rhythm despite the behavioral arrhythmicity of these ﬂies.
However, the electrophoretic mobility of PERDS, which by
comparison to wild-type PER should reﬂect the changing
phosphorylation states of the protein during a 24-h cycle
[31,32], was substantially altered such that chieﬂy hypophos-
phorylated protein accumulated throughout the cycle (Figure
7). As prior work has indicated that per-short domain
mutations enhance DBT activity [15], and we have shown in
this study that perDS ﬂies produce elevated levels of perDS
RNA, our results could indicate that PERDS proteins are
more efﬁciently phosphorylated and degraded than their
wild-type counterparts. Consistent with this view, previous
work has shown that in two mutants of the per-short domain,
per
S and per
T, hyperphosphorylated PER protein levels decline
prematurely during the early night [30], and a reduction of
DBT activity is associated with hypophosphorylation and
stabilization of wild-type PER (cf. [12,15]).
Discussion
Initial studies of dbt mutations suggested that PER is the
primary target of DBT in the Drosophila circadian clock. Loss
of dbt expression led to hypophosphorylation and over-
accumulation of PER in vivo [12]. Mutations of dbt that
shorten or lengthen behavioral rhythms led to correspond-
ingly earlier or later degradation of PER in ﬂy heads [12]. The
sequence of dbt suggested that it encodes an ortholog of the
CKI family of protein kinases in mammals [9]. Direct evidence
for DBT kinase activity and PER phosphorylation has been
hampered by the absence of speciﬁc enzymatic activity in
bacterially produced recombinant DBT preparations [10,33],
even though highly homologous mammalian CKIe (86%
primary sequence identity in the kinase domain) has been
recovered in an active form from bacterial expression
systems. It is possible that for Drosophila DBT, protein folding
is more sensitive to the cellular environment than the
mammalian enzyme. Alternatively, DBT may require post-
translational modiﬁcation(s) and/or the presence of a
stimulating activity or cofactor(s) to produce an active
conformation that is not available in bacterial cells. Never-
theless, in this report, we have shown that recombinant DBT
can be expressed and recovered in an enzymatically active
state from an insect cell line. However, even this insect-
derived activity is short-lived (S. Kivima ¨e, unpublished data).
Recombinant DBT in vitro preferentially phosphorylates
PER protein. No signiﬁcant phosphorylation was observed
when TIM, SGG, and CYC were used as a substrate in vitro.
Although no direct DBT phosphorylation of the N-terminal
half of CLK was observed, recent studies by others have
shown that DBT is required for the generation of a highly
phosphorylated and unstable form of CLK in vivo [4,34].
Furthermore, to achieve this highly phosphorylated state of
CLK, it has been suggested that PER must be present and
function as a bridge to physically deliver DBT to CLK [4].
CLK appears to be present in ﬂies in multiple isoforms,
including hypophosphorylated, intermediate-, and highly
phosphorylated states. The last form is only observed during
the late part of the CLK accumulation cycle and may promote
CLK degradation [34]. The lack of in vitro phosphorylation of
CLK by DBT in our current studies may reﬂect a DBT
phosphorylation target in the C-terminal half of CLK, or a
requirement for additional kinases to ‘‘prime’’ a DBT target,
or a dependence on PER for DBT-directed phosphorylation
of CLK.
Casein and PER are phosphorylated by enzymatically active
recombinant DBT, and mutations of dbt that are known to
affect the behavioral rhythm also have an effect on kinase
activity. The short- and long-period mutations dbt
S and dbt
L
[12] both reduce the kinase activity of DBT. Importantly,
when the dbt
S mutation was introduced speciﬁcally into the
Drosophila kinase, the effect was far less severe than a
previously reported orthologous substitution; using casein
as a substrate, the mutation produced a 15% decrease in
activity when composing the ﬂy kinase (this study), but
decreased enzyme activity by approximately 55% when
Table 2. Dosage-Dependent Shortening of the Period Length of Locomotor Activity Rhythms by perDS Transgenes
Genotype Transgenes, n Tau 6 S.D. Individuals Tested, n Arrhythmic Animals, n (%)
a
A, per
0;P [ perDS]x2 4 — 32 32 (100)
B, per
0;P [ perDS] 2 17.9 6 0.3 24 1 (4)
C, per
0;P [ perDS]/þ 1 20.0 6 0.2 25 —
D, per
þ;P [ perDS]x2 4 19.2 6 1.4 20 14 (70)
E, per
þ;P [ perDS] 2 21.4 6 0.2 26 —
F, per
þ;P [ perDS]/þ 1 22.7 6 0.2 20 —
Transgenic flies heterozygous for one perDS transgene, or homozygous for either one or two perDS transgenes, were tested in locomotor activity assays in DD. The average period of
locomotor activity rhythms (tau) for each genotype is indicated. P[perDS]x2 indicates the presence of four perDS transgenes. The effects of the transgenes were tested in a per-deficient
(per
0) (A–C) and in a wild-type background (D–F). Note for comparison, wild-type flies (in the absence of a transgene) exhibited locomotor activity rhythms with a period of 23.5 6 0.1 h
(unpublished data).
a The number of arrhythmic animals is shown with the percentage of arrhythmic flies with respect to the total flies tested (in parentheses).
S.D., standard deviation.
doi:10.1371/journal.pbio.0060183.t002
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DBT-Directed Phosphorylation of PERintroduced into Xenopus CKId [35]. Vertebrate CKI and DBT
include divergent C-terminal protein segments, and the
former enzyme cannot restore DBT function in transgenic
Drosophila [36]. These results suggest that any analysis of DBT
mutations in a heterologous system should be applied with
caution. The comparatively subtle effect of dbt
S on DBT
activity versus its strong effect on period length could reﬂect
a qualitative change in the mutant enzyme’s activity. An
Figure 7. PERDS Protein Expression in Flies with Two to Four perDS Transgenes
Western blot analyses of PER from fly heads collected at the indicated times in LD (indicated by altering open and closed horizontal bars). Newly eclosed
flies were entrained in LD for at least 3 d prior to collection. Genotypes assayed are indicated at the bottom of each panel (wt, wild type; [perDS]x2
indicates presence of two homozygous perDS transgenes (four copies total). PERDS protein signals are visible in the upper panels. Only PERDS proteins
were detected in transgenics due to the per null (per
0) background. DBT expression (lower panel) was used as a loading control.
doi:10.1371/journal.pbio.0060183.g007
Figure 6. Quantification of Clock Gene mRNA Expression
mRNA expression of cycling genes making up the circadian clock in flies was measured by northern blot or RNase protection from two time-course
experiments (one of which is shown in Figure S2). An average of the normalized values was obtained and plotted. Genes assayed are indicated to the
right of their respective profiles. RNA profiles on the left are from 12 h/12 h, light/dark cycles (LD, indicated by alternating open and closed horizontal
bars), right-side profiles are from DD time courses (constant darkness with subjective day indicated by hatched bar). Numbers on the vertical axes
indicate relative expression (maximal expression in wild type is 1.0). Numbers on the horizontal axes indicate time (hour within a 24-h cycle) when RNA
was collected. Blue, wild-type (wt) time courses; pink, time courses from flies homozygous for one perDS transgene (per
0;perDSx1); and yellow, time
courses from flies homozygous for two perDS transgenes (per
0;perDSx2). For (K) and (L), the green line represents the endogenous per RNA present in
the per
0 background, to which the levels were normalized. Notice the change in the scale due to the increased expression of perDS RNA. Error bars show
square root of variance from two independent samplings.
doi:10.1371/journal.pbio.0060183.g006
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from further mapping studies of the target speciﬁcities of
DBT
S versus DBT on PER substrates in vitro.
Three distinct regions of PER are preferentially phos-
phorylated by DBT in vitro. In the C-terminal region of PER,
we have identiﬁed two phosphorylation targets, serine 1,134
and threonine 1,219. No prior genetic or biochemical studies
have suggested a speciﬁc role for this PER interval, and our
cultured cell assays indicate that both phosphorylation
targets can be removed without a detectable effect on PER’s
function as a CLK repressor (Figure 5). Near the N-terminus
of PER, a region of 20 amino acids (residues 149–169)
contains ﬁve serines that are candidate phosphorylation sites
for DBT. This interval is located upstream of the PAS domain
of PER. A region important for DBT/PER binding in vitro has
been mapped to the ﬁrst 300 amino acids of PER [9].
However, we have not determined whether there is a closer
physical correspondence of the binding and phosphorylation
target sequences, or whether elimination of potential DBT
targets in this PER interval affects PER/DBT binding. As in
the case of our cultured cell studies of serine 1,134 and
threonine 1,219, elimination of all phosphorylation targets
between aa 149–169, produced no detectable effect on PER-
dependent repression in cultured cells.
Interestingly, two of the putative CKI sites, serine 151 and
serine 153, are substrates of casein kinase 2 [37]. Transgenic
ﬂies carrying S151A and/or S153A mutations showed period
lengthening and delayed PER nuclear localization. It will be
important in future studies to distinguish CK2 and DBT
phosphorylation targets in this region of PER and to
determine their individual and/or interactive effects on PER
function in vivo.
Of most interest in this study are phosphorylation sites
identiﬁed in the third DBT target region of PER, between
residues 580–645. This is a genetically well-studied interval
previously implicated in the regulation of behavioral
rhythms. As described earlier, mutations of a portion of this
region, the per-short domain (Figure 4), are predominantly
associated with short-period behavior [24,25,29]. The ﬁrst
mutation to be mapped to this region, per
S, [21,22,23]
eliminates a candidate phosphorylation site at serine 589,
and our S2 cell assays indicate that blocking phosphorylation
of this site enhances PER’s activity as a repressor of CLK
(Figure 5). Earlier work has also shown that per
S leads to
premature nuclear degradation of PER [30], and our current
studies of transgenic Drosophila producing a PER protein
truncated by 17 amino acids including serine 589 (perDS),
similarly indicate a role for this sequence in regulating PER
stability and function as a repressor (Figures 6 and 7). Thus,
the wild-type per-short domain appears to promote PER
stability while reducing its activity as a transcriptional
repressor.
We note that earlier work has also suggested that the
mutation per
S enhances DBT activity [15]. If serine 589 is no
longer an available DBT target in per
S, by what mechanism
might DBT function be elevated? Although mutating serine
589 enhances PER’s activity as a repressor, this response is
partially suppressed by a further mutation of some phos-
phorylation sites in the perSD region (Figure 5). As well, little
or no repressor activity is detected if all phosphorylation
targets are removed from perSD, even in the presence of the
per
S mutation (Figure 5). Together, these results suggest that
the phosphorylation state of serine 589 may inﬂuence DBT
activity on downstream targets within perSD that are
required for PER’s function as a CLK repressor. In such a
model (Figure 8), dephosphorylation of the per-short domain
would promote DBT-directed phosphorylation of perSD,
enhancing PER’s activity as a repressor and also destabilizing
the protein. Reciprocally, phosphorylation of serine 589
would depress activity of DBT with respect to perSD,
providing a more stable, but less active, PER protein. In this
view, a fully dephosphorylated state would provide the most
stable protein, but would provide an inactive form of PER,
consistent with our ﬁndings in cultured cells (Figure 5) and
Figure 8. Activity of the per-Short and perSD Domains Regulated by DBT Phosphorylation
A schematic of Drosophila PER protein is shown with the per-short (per-S) and per-short downstream (per-SD) domains highlighted. Residues
phosphorylated by DBT in vitro are indicated (P). Three phosphorylation states are indicated, as well as effects on stability and activity as suggested by
our studies of cultured cells and transgenic flies. It is proposed that phosphorylation of the per-short domain inhibits DBT-directed phosphorylation of
the per-short downstream domain (see text).
doi:10.1371/journal.pbio.0060183.g008
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DBT-Directed Phosphorylation of PERtransgenic ﬂies (Figure 7), and with earlier studies of DBT-
deﬁcient Drosophila [12,15]. Further in vivo evidence comes
from transgenic ﬂies expressing PER that contains a deletion
of a conserved segment (aa 516–568) downstream of the PAS
domain [38]. This mutant PER protein displays increased
stability and low-amplitude oscillations. More importantly,
high levels of a hypophosphorylated form of PER are
produced by these truncated proteins, which constitutively
accumulate in the nucleus. This protein appears to have little
or no activity as a transcriptional repressor [38].
Earlier studies of PER repression in S2 cells identiﬁed a
region of PER, distinct from those reported here, that is also
required for PER’s function as a repressor of CLK-mediated
transcription (CLK-CYC inhibition domain [CCID], aa 764–
1,034; [39]). A novel, bipartite nuclear localization signal
(NLS) is found in this region that inﬂuences nuclear local-
ization of PER in S2 cells. Recent mapping studies of CCID
led to the identiﬁcation of a smaller, PER-DBT binding
domain (PDBD; aa 755–809) that upon deletion increases PER
stability, decreases PER phosphorylation, and severely im-
pairs PER function as a transcriptional repressor [40]. A
related deletion of PER (aa 768–792) produced similar
defects, and impaired nuclear accumulation of PER in
cultured cells [41]. Studies of the latter deletion in transgenic
ﬂies showed that a hypophosphorylated form of PER is
constitutively expressed at high levels and is a very poor
repressor. However, repressor function was restored by NLS
addition, suggesting that dysfunction of the protein was likely
due to its inability to localize to the nucleus [41].
The arrangement of four of the phosphorylation targets
included within the perSD domain (serines 604, 607, and 613,
and threonine 610) resembles a CKI phosphorylation motif
found in human PER2 that has been implicated in FASPS. In
the human PER protein, there are ﬁve serines spaced in an
arrangement such that every third amino acid residue is a
serine. These ﬁve serines are thought to be progressively
phosphorylated by CKIe/d, and in certain FASPS subjects, the
ﬁrst serine is mutated to glycine [42]. It has been proposed
that this mutation inhibits the phosphorylation of the
remaining serines, thus leading to altered hPER2 levels or
activity in FASPS subjects [42]. In fact, more-recent studies of
this mutation indicate that it may alter PER29s repressor
function because lower levels of mper2 RNA are found in
transgenic mice expressing the similarly mutated mPER2
protein [43]. Cultured cell studies have also suggested that the
mutation affects mPER2 stability [44]. Accordingly, a role for
CKI-directed phosphorylation in the regulation of PER’s
stability and activity as a transcriptional repressor may be
conserved from ﬂies to mammals.
Materials and Methods
Maintenance of cultured cells. Sf9 cells (Invitrogen) were main-
tained at 28 8C in serum-free medium Sf-900 II SFM according to the
supplier’s recommendation. A new batch of cells was used every 3–4
mo. S2 cells were maintained at room temperature in Drosophila SFM
medium (Invitrogen) supplemented with 15% fetal bovine serum and
1.5 g L-glutamine/500 ml.
Cloning of plasmid constructs. PER coding sequences were
ampliﬁed by PCR and cloned between EcoRI and XhoI sites in a
pGEX6P-1 expression plasmid. For GST-SGG and GST-CYC, full-
length open reading frames of sgg and Bmal were ampliﬁed by PCR
and cloned into pGEX-6P-1 between SmaI and NotI sites and EcoRI
and XhoI sites, respectively. For GST-DBT, the dbt open reading
frame was PCR ampliﬁed and cloned as an EcoRI-XhoI fragment into
pGEX-6P-1 vector. GST-TIM constructs have been described before
[45].
For GST-DBT baculovirus construction, the GST-DBT coding
sequence from pGEX-6P-1 vector was released as an SspI fragment
and ligated in EcoRV site in the pFastBac-1 vector (Invitrogen). The
resulting pFastBac-GST-DBT construct was used to transform
DH10Bac competent cells (Invitrogen), and recombinant baculovirus
DNA was selected and puriﬁed following the Bac-to-Bac system
(Invitrogen) instructions. Baculovirus encoding for DBT mutants
were constructed analogously, except point mutations changing the
relevant amino acids were ﬁrst introduced into the dbt coding
sequence.
For S2 cell expression, per cDNA was cloned into a pAct plasmid.
Point mutations into the per coding sequence were introduced by
following the QuickChange II (Stratagene) mutagenesis protocol.
Expression plasmids encoding for luciferase, Clk, and lacZ under actin
promoter control have been described [46]. per-luc reporter construct
contains a luciferase coding sequence under a per gene promoter
cloned into a pCasper-4 plasmid [47].
Expression and puriﬁcation of recombinant PER proteins from E.
coli. Proteins were expressed in BL21pLysS cells (Novagen). Protein
expression was induced with 1 mM IPTG at a cell density of optical
density at 600 nm (OD600) ¼ 0.6–0.8 for 3–4 h at 37 8C. After
induction, cells were pelleted and resuspended in STE buffer (150
mM NaCl, 50 mM Tris [pH 8.0], 1 mM EDTA), and sarcosyl in STE was
added to a ﬁnal concentration of 1%. Resuspended cells were frozen
once. Thawed lysate was passed through an 18-gauge syringe needle
ﬁve times to fragment DNA. Shared lysate was centrifuged at 15,000g
for 30 min at 4 8C. After centrifugation, Triton X-100 in STE was
added to the supernatant to 2% ﬁnal concentration and incubated
with glutatione sepharose for 30 min at 4 8C. Bound protein was
washed once with HND600 buffer (600 mM KCl, 20 mM Tris [pH 7.5],
5 mM EDTA, 10% glycerol, 0.5% Tween 20) and four times with
HND100 (same as HND600 except with 100 mM KCl). Bound proteins
were stored at  20 8C in 50% glycerol/HND600.
Expression and puriﬁcation of recombinant DBT proteins from Sf9
cells. Sf9 cells were transfected with baculovirus DNA containing the
GST-DBT expression cassette using Lipofectamine (Invitrogen)
according to the manufacturer’s recommendations. At 72 h after
transfection, cell culture medium was collected, and transfected cells
were lysed and tested for GST-DBT protein expression by western
blot analysis. Anti-GST antibody (Santa Cruz Biotechnology) was used
to detect recombinant protein expression. Cell culture medium from
cells that tested positive for recombinant protein expression was used
to infect cells for 48 h to produce GST-DBT baculovirus stocks. Viral
stocks were stored at 4 8C. For protein expression, 0.3–1 ml of viral
stock was used to infect approximately 1.5 3 10
7 adherent cells in a
150-cm
2 tissue culture ﬂask in 25 ml of medium. Cells were lysed 48 h
after infection in HND100 buffer on ice for 10 min in the presence of
protease inhibitors III (Calbiochem). Lysates were cleared by
centrifugation at 15,000g for 10 min. After centrifugation extracts
were incubated shaking with glutathione sepharose at 4 8C for 30 min.
Resin with bound protein was washed three times with lysis buffer
and once with PreScission protease cleavage buffer (150 mM NaCl, 50
mM Tris [pH 7.5], 1 mM EDTA). Recombinant DBT protein was
cleaved off the glutathione sepharose in overnight incubation with
PreScission protease (Amersham) in 0.5 ml of protease buffer
following the conditions recommended by the manufacturer. Next-
day supernatants from protease cleavage were concentrated approx-
imately 20-fold by ultraﬁltration in Microcon centrifugal ﬁlters with
molecular cutoff of 30 kD (Millipore). Resulting concentrates were
used within hours for kinase assays (and contained ;50 ng protein/
ll). The activity was diminished to almost undetectable levels in 24 h
after puriﬁcation.
In vitro protein phosphorylation. GST-PER fusion proteins bound
to glutathione sepharose beads were washed once with kinase buffer
(50 mM Tris [pH 7.5], 10 mM MgCl2, 5 mM DTT) and resuspended in
kinase buffer. A stock solution containing DBT protein puriﬁed from
Sf9 cells was added (1/10 total reaction volume, 5 ng/llﬁ n a l
concentration) to resuspended beads after addition of 0.5 ll
radioactive ATP labeled with P-32 at c-phosphate (3,000 Ci/mmol)
and 100 lM unlabeled ATP. Reactions were carried out in 30 ll and
were allowed to proceed for 1 min at room temperature to reduce
nonspeciﬁc phosphorylation. Reactions were stopped by adding
equal volume of 23SDS-PAGE loading buffer (125 mM Tris [pH 6.8],
4% SDS, 20% glycerol, 10% b-mercaptoethanol [v/v]). Phosphory-
lated proteins in SDS-PAGE loading buffer were boiled for 5 min and
were resolved in 10% SDS-PAGE. Reactions with casein were carried
out in similar conditions, except DBT proteins were not cleaved off
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in each reaction.
Phosphopeptide sequencing and mass spectrometry. DBT-phos-
phorylated (32P) GST-PER fusion proteins were resolved in acryl-
amide gels and then stained and excised for subsequent analysis at the
Rockefeller University Protein Research Facility according to facility
procedures. Phosphorylated proteins were digested with trypsin, and
the resulting peptides were resolved into approximately 100 fractions
for each protein by reverse-phase high-performance liquid chroma-
tography (HPLC) using a VYDAC C18 column (1.0-mm ID3250-mm
length) in a HPLC Agilent model 1100. Fractions that contained the
majority of the radioactivity were treated individually with alkaline
phosphatase and propanethiol (Figure S3). Treated fractions were
analyzed by mass spectrometry, and peptide masses of treated and
nontreated samples were compared. Alkaline phosphatase hydrolysis
reduces peptide mass by 80 Da per phosphorylated residue. As an
independent test, phosphopeptides were reacted with propanethiol.
This results in a substitution reaction at the phosphorylation site and
reduces peptide mass by 21 Da per phosphorylated residue. Peptide
fractions that responded to both treatments were subjected to Edman
sequencing to identify the position of individual phosphorylated
amino acids in the peptides.
Luciferase assay. Luciferase assays were carried out essentially as
described [45]. S2 cells were transfected in 24-well plates at 60%–80%
conﬂuency using Effectene transfection reagent (Qiagen) following
the manufacturer’s recommendations. Cells were transfected with 50-
ng pAct-PER, encoding for either wild-type or mutant PER, 5-ng
pAct-Clk, 10-ng per-luc, 20-ng pAct-lacZ, and 115 ng of pAct plasmid
without an insert. Transcription in these assays depends on
endogenously produced CYC and pAct-Clk–induced TIM (cf. [48]).
Cells were harvested 24–36 h after transfection and lysed in Cell
Culture Lysis Reagent (Promega). Extracts were mixed with Lucifer-
ase Assay Reagent (Promega) in a 1:5 ratio, and luciferase activity was
measured using liquid scintillation counter LS6000IC (Beckman) in
single-photon collection mode. Luciferase activity was normalized to
cotransfected b-gal activity in each sample. To determine the amount
of PER protein present in each luciferase assay, a small sample was
subjected to SDS-PAGE, and the presence of PER protein was
detected using anti-PER antibodies. To quantitate the strength of
repression as a function of the amount of protein, S2 cells were
transfected with increasing amounts of per DNA. Half of each cell
sample was used to measure PER-dependent repression, with the
remaining half used to determine the amount of PER protein in the
assay.
Protein extraction and western analysis. Total protein from ﬂy
heads was extracted in HE buffer (20 mM Tris [pH 7.5], 100 mM KCl,
10 mM EDTA, 0.1% Triton, 1 mM DTT) supplemented with protease
and phosphatase inhibitors (Calbiochem). Protein concentration was
measured with BCA protein measurement kit (Pierce) according to
the manufacturer’s protocol.
For detection of PER and TIM proteins, 20 lg of total protein was
resolved in 6% SDS-PAGE. The following antibodies at indicated
dilutions in 5% nonfat milk were used for protein detection: anti-
TIM 1:2,000 [49], anti-PER 1:20,000 (gift from Dr. J. Hall), or anti-PER
1:600 (Chemicon). Appropriate species-speciﬁc horseradish perox-
idase–coupled secondary antibodies (Jackson Laboratories) were used
at 1:10,000 dilution. Antibody binding was detected by ECL western
blotting detection reagent (Amersham). Primary antibody incuba-
tions were carried out overnight at 4 8C. Secondary antibody
incubations were carried out at room temperature for 1 h. Blots
were washed with 13TBST (50 mM Tris [pH 8.0], 150 mM NaCl, 0.5%
Tween 20) three times for 10 min. Secondary antibody incubations
were also carried out in 13 TBST.
RNA isolation and northern analysis. RNA was isolated from ﬂy
heads by homogenization in RNA STAT-60 extraction reagent (TEL-
TEST) according to the manufacturer’s protocol or with RNeasy RNA
isolation kit (Qiagen) according to animal cell RNA isolation protocol
with additional centrifugation after initial homogenization of ﬂy
heads and prior to column binding. Two micrograms to 20 lg of total
RNA was resolved in 1% formaldehyde gel following the RNeasy
Northern gel protocol and transferred to NytranN membrane
(Schleicher and Schuell) in 103SSC. Membranes were UV crosslinked
in Stratalinker (Stratagene). Prehybridization was carried out for 0.5–
2 h, and hybridization was performed overnight in 10 ml of Ultrahybe
buffer (Ambion). Blots were washed four times in washing buffer
(0.23SSC, 1% SDS) at 65 8C. Signal was detected and quantiﬁed with
Typhoon 9200 imager (Amersham).
Radioactive probes were generated using a Decaprime II (Ambion)
DNA labeling kit according to the manufacturer’s protocol. Full
cDNA sequences were used to make probes for detection of per, tim,
vri, clk, dbt, cyc, and rp49 mRNAs. For pdp1e mRNA detection,
sequence speciﬁc for the e isoform was used as a template for probe
synthesis.
RNase protection assay. RNase protection assays were carried out
using an RPAIII kit (Ambion) according to the manufacturer’s
protocol. For hybridization, 2–5 lg of total RNA from ﬂy heads was
used. For probe generation, a fragment of per genomic sequence
containing the last 110 nt from intron 4 and the ﬁrst 311 nt from
exon 5 was ampliﬁed by PCR and cloned into pBluescript plasmid
between EcoRI and Xho sites in the direction that allowed the
antisense strand to be transcribed by T7 polymerase. This probe
protects the 311 nt of per mRNA that includes the per-short domain.
In perDS ﬂies, the protected fragment is 51 nt shorter. Probe synthesis
was carried out using a MaxiScript kit (Ambion) according to the
manufacturer’s protocol.
Fly culture and locomotor behavior analysis. Drosophila melanogaster
were reared on standard medium at room temperature (;25 8C).
Monitoring and analysis of locomotor activity of individual ﬂies was
performed in constant darkness at 25 8C using the Drosophila Activity
Monitoring System IV (Trikinetics).
Generation of perDS transgenes. Single-stranded DNA (ssDNA)
site-directed mutagenesis with phosphorothioate incorporation [50]
was used to delete the per-short region of the per gene. Brieﬂy, a
30mer oligonucleotide, of which 15 nt mapped 59 and 15 nt mapped
39 of per deletion (indicated by ‘‘jj’’ below), was synthesized (59-AAC
GAG TTG ACC GTCjjTAT GAC AGT AAG AGT-39). The oligonu-
cleotide was phosphorylated with T4 polynucleotide kinase and
annealed to the ssDNA XmaI-XmnI fragment recovered from per
genomic DNA and cloned in pGEM 7-zf. The second strand was
synthesized with DNA polymerase (Klenow fragment), and T4 DNA
ligase was added to close the gap of the new strand. Nci I and
exonuclease III were used to nick and then partially digest the parent
strand. The mutant homoduplex was formed by incubating this
partially double-stranded DNA in the presence of DNA polymerase I
and T4 DNA ligase. PCR and DNA sequencing conﬁrmed the
deletion, and the fragment was cloned in the context of full-length
genomic per DNA and pCasPer transformation vector. Transgenic
ﬂies carrying the perDS construct were generated and mapped by
standard protocols.
Supporting Information
Figure S1. Locomotor Activity of perDS ﬂies
Flies were entrained to an LD cycle for 3 d before testing. Thereafter,
locomotor activity of individual ﬂies was recorded in constant
darkness at 25 8C. Representative actograms (top) and periodograms
(bottom) for each genotype assayed are shown. For each periodo-
gram, the lower limit of statistical signiﬁcance (p , 0.01) is indicated
by a slanted line.
Found at doi:10.1371/journal.pbio.0060183.sg001 (112 KB PDF).
Figure S2. mRNA Expression of Cycling Clock Genes in Flies
Homozygous for One or Two perDS Transgenes
RNA samples were collected for 1 d in LD (indicated by altering open
and closed horizontal bars in (A), (C), and (E)), and 1 d in DD
(subjective day indicated by hatched bars, in (B), (D), and (F)).
Genotypes are shown at the bottom of each panel, and RNA proﬁles
assessed are indicated on the left. Constitutive tubulin, rp49, and cyc
mRNAs were measured for normalization. (E) and (F) are the results
of an RNAase protection assay. Top, middle, and bottom bands in (E)
and (F) represent protected fragment for tubulin, endogenous per
gene mRNA, and protected fragment from transgenic perDS,
respectively. Numbers indicate hours in a 24-h cycle when RNA was
collected.
Found at doi:10.1371/journal.pbio.0060183.sg002 (715 KB PDF).
Figure S3. Mass Spectrometry of PERIOD Protein Phosphorylated by
DBT
Recombinant PER fragments were individually phosphorylated with
DBT and digested with trypsin. (A) and (B) were derived from peptide
606-SSTETPPSYNQLNYNENLLR-625. Each peptide fraction con-
taining the majority of the radioactivity was treated with propane-
thiol (A) or phosphatase (B) and analyzed by mass spectrometry. The
peptide masses of untreated (top) and treated samples (bottom) were
compared to identify the phosphorylated residue(s).
(A) shows an example of propanethiol treatment. Notice the change
in the masses of the peptide 2422.29 after treatment due to a
PLoS Biology | www.plosbiology.org July 2008 | Volume 6 | Issue 7 | e183 1581
DBT-Directed Phosphorylation of PERsubstitution reaction at the phosphorylation site, which reduces
peptide mass by 21 Da per phosphorylated residue, improving
ionization efﬁciency.
(B) shows the results obtained following alkaline phosphatase treat-
ment, leading to a reduction of peptide mass by 80 Da per
phosphorylated residue. Peptide fractions that responded to both
treatments were subjected to Edman sequencing to identify the
position of individual phosphorylated amino acids in the peptides.
(C) is a tandem mass spectrometry (MS/MS) spectrum of the PER
peptide 1124-EVPDSSPIPSVMGDYNSD-1143, which is phosphory-
lated at position 10 (S-1134). The MS/MS spectrum shows a doubly
charged ion at m/z 994.9 (Pre) corresponding to the mass of the
phosphorylated peptide. A loss of 98 Da (H3PO4) was observed for
this precursor and some fragment ions under low collision-induced
dissociation. The peaks labeled y1–7 and b6–9 correspond to the
masses of b and y fragment ions of unmodiﬁed peptides. The addition
of 80 Da (mass of PO3) was observed for the b10 (b10þ80) and y9
(y9þ80) ions, demonstrating that phosphorylation was on the Ser at
position 10.
Found at doi:10.1371/journal.pbio.0060183.sg003 (335 KB PDF).
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